Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis
Mitochondria are dynamic organelles that play a key role in energy conversion. Optimal mitochondrial function is ensured by a quality-control system tightly coupled to fusion and fission. In this connection, mitofusin 2 (Mfn2) participates in mitochondrial fusion and undergoes repression in muscle f...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 109; no. 14; pp. 5523 - 5528 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
03.04.2012
National Acad Sciences |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8424 1091-6490 1091-6490 |
DOI | 10.1073/pnas.1108220109 |
Cover
Summary: | Mitochondria are dynamic organelles that play a key role in energy conversion. Optimal mitochondrial function is ensured by a quality-control system tightly coupled to fusion and fission. In this connection, mitofusin 2 (Mfn2) participates in mitochondrial fusion and undergoes repression in muscle from obese or type 2 diabetic patients. Here, we provide in vivo evidence that Mfn2 plays an essential role in metabolic homeostasis. Liver-specific ablation of Mfn2 in mice led to numerous metabolic abnormalities, characterized by glucose intolerance and enhanced hepatic gluconeogenesis. Mfn2 deficiency impaired insulin signaling in liver and muscle. Furthermore, Mfn2 deficiency was associated with endoplasmic reticulum stress, enhanced hydrogen peroxide concentration, altered reactive oxygen species handling, and active JNK. Chemical chaperones or the antioxidant N-acetylcysteine ameliorated glucose tolerance and insulin signaling in liver-specific Mfn2 KO mice. This study provides an important description of a unique unexpected role of Mfn2 coordinating mitochondria and endoplasmic reticulum function, leading to modulation of insulin signaling and glucose homeostasis in vivo. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1108220109 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 PMCID: PMC3325712 1D. Sebastián, M.I.H.-A., and J.S. contributed equally to this work. Edited* by Bruce M. Spiegelman, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, and approved February 7, 2012 (received for review June 21, 2011) Author contributions: D. Sebastián, M.I.H.-A., J.S., E.S., J.P.M., D. Sala, A.W., J.C.P., S.P., R.B., and A.Z. designed research; D. Sebastián, M.I.H.-A., J.S., E.S., J.P.M., D. Sala, J.C.P., P.G., and S.P. performed research; M.L. contributed new reagents/analytic tools; D. Sebastián, M.I.H.-A., J.S., E.S., J.P.M., D. Sala, J.C.P., M.O., S.P., R.B., M.P., and A.Z. analyzed data; and A.Z. wrote the paper. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1108220109 |